Eric A. Adams - Jan 24, 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
President & CEO, Director
Signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Eric A Adams
Stock symbol
INM
Transactions as of
Jan 24, 2022
Transactions value $
$0
Form type
4
Date filed
1/24/2022, 03:18 PM
Previous filing
Oct 19, 2021
Next filing
Apr 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -60.6K -12.83% $0.00 412K Jan 24, 2022 Common shares 60.6K $2.10 Direct F1
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -60.6K -14.72% $0.00 351K Jan 24, 2022 Common shares 60.6K $2.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$2.64 using an exchange rate of C$1.2554 = $US1.00
F2 Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00